APA (7th ed.) Citation

Fenn, J., Ridgley, L. A., White, A., Sarfas, C., Dennis, M., Dalgleish, A., . . . Bodman-Smith, M. (2022). Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2+ T cells compared with the aminobisphosphonate drug zoledronic acid. Clinical & Experimental Immunology, 208(3), 301. https://doi.org/10.1093/cei/uxac032

Chicago Style (17th ed.) Citation

Fenn, J., L A. Ridgley, A. White, C. Sarfas, M. Dennis, A. Dalgleish, R. Reljic, S. Sharpe, and M. Bodman-Smith. "Bacillus Calmette-Guerin (BCG) Induces Superior Anti-tumour Responses by Vδ2+ T Cells Compared with the Aminobisphosphonate Drug Zoledronic Acid." Clinical & Experimental Immunology 208, no. 3 (2022): 301. https://doi.org/10.1093/cei/uxac032.

MLA (9th ed.) Citation

Fenn, J., et al. "Bacillus Calmette-Guerin (BCG) Induces Superior Anti-tumour Responses by Vδ2+ T Cells Compared with the Aminobisphosphonate Drug Zoledronic Acid." Clinical & Experimental Immunology, vol. 208, no. 3, 2022, p. 301, https://doi.org/10.1093/cei/uxac032.